Lauren Santye, Assistant Editor

Lynparza is a first in class PARP inhibitor for the monotherapy treatment of patients with metastatic castration resistant prostate cancer.

Venetoclax is an inhibitor of the B-cell lymphoma-2 protein used in combination with hypomethylating agents in treatment-naive AML patients.

Adcetris is currently the only approved molecular-targeted therapy for Hodgkins lymphoma.

NFL Hall of Famer and Super Bowl champion Mike Haynes seeks to spread awareness about prostate cancer following his fight with the disease.

Researchers seek to predict age-related responses to hepatitis B vaccination.

Handheld miniature microscope allows surgeons to see cancer at a cellular level.

Study finds decreased spending is not due to enrollees switching to lower cost providers.

Study finds passage of Affordable Care Act caused a spike in ER visits for young adults with mental illnesses and circulatory system disease.

Abraxane and gemcitabine evaluated in first-line patients with metastatic pancreatic cancer.

Abraxane and gemcitabine evaluated in first-line patients with metastatic pancreatic cancer.

Centers for Medicare and Medicaid Services issues final ruling that seeks to rein in the growing cost of prescription drugs.

Inherited genetic markers in immune response pathways associated with melanoma survival.

ART treatment results in higher CD4+ T-cell frequency, lower cellular activation, and higher proportions of naive T-cells.

The expanded use of Opdivo and Yervoy includes patients with BRAF V600 wild-type mutation-positive unresectable or metastatic melanoma.

Researchers stress that no conclusions can be drawn yet about the safety of cannabis and cannabinoid research.

The expanded use of Opdivo and Yervoy includes patients with BRAF V600 wild-type mutation-positive unresectable or metastatic melanoma.

New method may offer safer alternative to target tumors and minimize awful side effects for cancer patients.

Researchers stress that no conclusions can be drawn yet about the safety of cannabis and cannabinoid research.

ART treatment results in higher CD4+ T-cell frequency, lower cellular activation, and higher proportions of naive T-cells.

Researchers find mechanism that enables cells to migrate in a specific tissue.

Centers for Medicare and Medicaid Services issues final ruling that seeks to rein in the growing cost of prescription drugs.

Partisan split found in those who believe America should devote more funds to global health care initiatives.

Researchers find cancer evolves in specific patterns that are predictable through the laws of nature.

Genetic modifications enhance local DNA repair and protection in cancer treatment.

Some patients with amyotrophic lateral sclerosis who received the stem cell therapy showed less progression and improved respiratory and motor functions.

ACOs combined for a total net savings of $411 million in 2014.

Aggressive surgery to remove all cancer cells followed by targeted chemotherapy shows potential to significantly improve ovarian cancer survival.

A young Navy veteran finds hope in his struggle with amyotrophic lateral sclerosis, as the hunt for a cure continues.

Venetoclax is a B-cell lymphoma-2 protein inhibitor for the treatment of CLL patients who received a least one prior therapy.

Tumors that over-express a specific oncogene may benefit from combination therapy regardless of cancer type.